Market Overview

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

20.09 -0.04 (-0.20%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/16/20Piper SandlerUpgradesOverweight31.0
6/15/20JefferiesReinstatesHold24.0
4/16/20StifelMaintainsHold24.0
11/07/19Stifel NicolausDowngradesHold23.0
11/06/19JefferiesDowngradesHold
12/17/18MizuhoMaintainsBuy63.0
11/12/18B. Riley FBRMaintainsBuy65.0
9/18/18MizuhoInitiates Coverage OnBuy61.0
8/09/18JefferiesMaintainsBuy58.0
5/25/18Stifel NicolausMaintainsBuy60.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter